dbACP: A Comprehensive Database of Anti-Cancer Peptides

27 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07023 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 15.05 ± 8.51 µM
dbacp07024 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 31.63 ± 1.56 µM
dbacp07025 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 14.52 ± 1.44 µM
dbacp07026 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 14.75 ± 7.35 µM
dbacp07027 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 22.36 ± 6.07 µM
dbacp07028 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 13.04 ± 1.99 µM
dbacp07029 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 15.25 ± 0.80 µM
dbacp07030 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 5.69 ± 1.46 µM
dbacp07031 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 14.31 ± 1.37 µM
dbacp07032 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 3.79 ± 1.61 µM
dbacp07033 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 4.42 ± 0.06 µM
dbacp07034 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 8.71 ± 0.35 µM
dbacp07035 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 6.31 ± 0.66 µM
dbacp07036 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 4.72 ± 0.36 µM
dbacp07037 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 3.77 ± 0.12 µM
dbacp07038 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 5.49 ± 0.37 µM
dbacp07039 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 3.74 ± 3.46 µM
dbacp07040 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 2.31 ± 0.08 µM
dbacp07041 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 6.94 ± 0.27 µM
dbacp07042 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 1.84 ± 0.17 µM
dbacp07043 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 2.24 ± 0.05 µM
dbacp07044 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 35.71 ± 8.50 µM
dbacp07045 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 70.71 ± 5.39 µM
dbacp07046 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 33.92 ± 5.90 µM
dbacp07047 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 57.45 ± 6.03 µM
dbacp07048 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 57.99 ± 5.04 µM
dbacp07049 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 57.03 ± 6.09 µM